RecruitingPhase 2NCT04933669

Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors

Studying Gastrointestinal stromal tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
First Affiliated Hospital of Zhejiang University
Principal Investigator
Jiren Yu
Zhejiang University
Intervention
Imatinib(drug)
Enrollment
122 target
Eligibility
18-80 years · All sexes
Timeline
20212029

Study locations (1)

Collaborators

Second Affiliated Hospital, School of Medicine, Zhejiang University · Sir Run Run Shaw Hospital · Zhejiang Cancer Hospital · First Affiliated Hospital of Wenzhou Medical University · Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University · Ningbo No. 1 Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04933669 on ClinicalTrials.gov

Other trials for Gastrointestinal stromal tumor

Additional recruiting or active studies for the same condition.

See all trials for Gastrointestinal stromal tumor

← Back to all trials